The University of Kentucky Center for Molecular Medicine sponsors three scientific cores for use by researchers at the University of Kentucky.  These include a Protein core providing services for the production and characterization of proteins, an Organic Synthesis core synthesizing small molecules not commercially available, and a Genetic Technologies core producing recombinant virus and oth

Do you receive funding alerts from the University’s Proposal Development Office?  You can subscribe to receive these email notices based on your area(s) of research interest.  A subscription form is found by clicking here

 

[From the July 17 NIH “eSubmission Items of Interest”]

You may have noticed that newer NIH funding opportunity announcements (FOAs) have a different look. Some aspects of the old format (e.g., table structure) did not allow for easy page resizing across electronic devices and had to be reworked. You should now find it easier to view FOAs on various screen sizes of phones, tablets, laptops, desktops and other electronic devices. Despite challenges, NIH is striving to retain the integrity of the FOA information in a responsive format.

OSPA’s Useful Proposal Information page (http://www.research.uky.edu/ospa/info.html) has been updated.  One item in particular is that previously they had recommended a health insurance escalation of more than 10% in multi-year grant proposal budgets.  After looking at the actual increases over the past 5 years, they determined that number was no longer an accurate reflection.  It has been changed so that they now recommend a 3% escalation for health care costs.   The SRAS will incorporate this reduction

The Radiation Medicine Department in the College of Medicine at the University of Kentucky currently offers a comprehensive program leading to the M.S. degree in Radiological Medical Physics. The program provides students a thorough didactic grounding in fundamental and specialized medical physics, with hands-on experience using state-of-the-art equipment, and is fully accredited by the Commission on Accreditation of Medical Physics Programs (CAMPEP).

The UK Radiological Medical Physics program:

Susan Parker a nursing professional, runner and passionate equestrian was diagnosed with Stage IIIB Adenocarcinoma of the lung in 2011. Immediately after her diagnosis, she began the 31-day regimen of daily radiation treatments combined with chemotherapy. “I went to those initial appointments with the oncologists not at all sure that I wanted to pursue treatment,” said Susan. “But Dr. McGarry’s big smile and his very positive attitude go a long way to encourage a patient who has been given this kind of diagnosis.

A new study by University of Kentucky researchers shows how a genetic defect in a specific hormonal pathway may make people more susceptible to developing melanoma, the deadliest type of skin cancer. Fair-skinned people who tend to burn (rather than tan) from sun exposure have a much higher risk for melanoma than darker-skinned people. On the surface, it appears that the amount of melanin, the natural substance in the skin that determines pigment and acts as the skin's "natural sunscreen," would be the only determinant of melanoma risk.
The Bright Focus Foundation has announced that three different researchers from the Sanders-Brown Center on Aging at the University of Kentucky have received Bright Focus grants for 2014. Professor Steve Estus and associate professors Harry LeVine and Paul Murphy were each recognized for their work on Alzheimer's disease. "Only 25 Bright Focus grants are awarded worldwide each year, so it's an achievement to get one. But three Bright Focus grants in a single year is truly exceptional," said Dr. Michael Karpf, UK HealthCare's executive vice president of health affairs.
On May 7, 2014, the 1st Annual Department of Radiology Quality & Safety Forum took place, sponsored by Dr. Bernard Boulanger and the UK HealthCare Office of Enterprise Quality & Safety. Eight Radiology Quality & Safety projects were displayed to the public, and a winner chosen by secret panel. The event hosted many observers, including Dr. Michael Karpf. Dr. Sarah Deraney’s (R2) poster was chosen as the winning project. Dr. Deraney went on to present her poster again on June 11, 2014, at the Quarterly Report on Quality.
A year ago, a crowd of hundreds gathered in Pavilion A of the University of Kentucky Chandler Hospital to celebrate a long-awaited special announcement – the unveiling of the UK Markey Cancer Center as the state's first and only National Cancer Institute-designated cancer center. The designation was the culmination of years of tireless work by the faculty and staff of Markey and its supporting service lines and colleges – all guided by Director Dr.